Full-Time

Mechanic 2

Posted on 8/14/2025

PCI Pharma Services

PCI Pharma Services

1-10 employees

Pharmaceutical packaging and contract services

No salary listed

Philadelphia, PA, USA

In Person

Category
Mechanical Engineering (1)
Requirements
  • Must be experienced with the ADD/BBV equipment.
  • Must have proven success in changeovers and production coverage of the ADD/BBV specific equipment.
  • A minimum requirement of four thousand (4,000) OJT hours and one hundred fifty (150) technical training hours. Or has previously trained and successfully completed an equivalent.
  • Three (3+) years equivalent experience as a mechanic I, II with the equivalent technical training.
Responsibilities
  • Responsible for mechanical equipment repair and troubleshooting, process improvements, equipment changeovers, fabrication of machine parts on packaging machinery, as per training administered.
  • Demonstrate competency in all requirements for Mechanic Level I.
  • Describe all machine controls, where trained, and their functions.
  • Identify all safety devices and emergency switches on all lines and equipment.
  • Verify understanding of all safety procedures, where trained.
  • Operate all equipment, where trained, in ADD/BBV areas.
  • Operate and interface with online computers.
  • Demonstrates Precision Mechanical-troubleshooting abilities, identifies and resolves issues utilizing systematic problem-solving methods specializes in ADD/BBV areas.
  • Perform changeovers, where trained.
  • Perform preventive maintenance tasks, where trained, on designated equipment.
  • Maintains records and documentation as required.
  • Maintains work area, tools and equipment in a clean and safe order.
  • Provide guidance, assistance, leadership, and training to Mechanic Level I in the performance of their duties.
  • Exhibits flexibility acquired through training to be utilized at any position as needed in the company, or elsewhere in the facility, or as a trainer.
  • Perform and Document all equipment Challenges that are list per MPI.
  • Demonstrate good documentation practices on mechanical setup logbooks.

PCI Pharma Services offers end-to-end pharmaceutical packaging and related services, including Folding Cartons, Labels, Contract Packaging, Clinical Services, and Brand Protection. It serves as a one-stop source for healthcare product developers and manufacturers, handling carton and label production, packaging operations, clinical services, and brand protection under one roof. The company stands out with eight decades of experience, strict cGMP and ISO compliance, lean manufacturing, ongoing R&D, and comprehensive employee training, security, hygiene, and inspection practices. Its goal is to be a trusted, end-to-end packaging partner that delivers reliable, compliant, and scalable packaging solutions, so clients can focus on their core business.

Company Size

1-10

Company Stage

Debt Financing

Total Funding

$4B

Headquarters

Burlington, Canada

Founded

1971

Simplify Jobs

Simplify's Take

What believers are saying

  • GLP-1 surge drives demand for PCI's prefilled syringes and autoinjectors.
  • Oncology-CNS pipelines favor PCI's patient-centric drug-device combinations.
  • Bain Capital's $10B valuation fuels $1B capacity expansions through 2028.

What critics are saying

  • San Diego isolator line delays to H1 2028 cede contracts to Lonza.
  • Novo Nordisk's Catalent acquisition slashes external CDMO fill-finish availability.
  • PE backers force divestitures if biotech funding dries post-2025.

What makes PCI Pharma Services unique

  • PCI integrates sterile fill-finish with drug-device assembly for end-to-end injectables.
  • Ajinomoto Althea acquisition adds rare US high-potent ADC sterile filling expertise.
  • AVI systems inspect 75 million vials annually, scaling quality without bottlenecks.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

401(k) Retirement Plan

Health Savings Account/Flexible Spending Account

Company News

BioProcess International
Aug 15th, 2025
Building a better facility: BPI tours PCI manufacturing plant in Bedford

On the last day of June 2025's BIO conference in Boston, Massachusetts, contract development and manufacturing organization (CDMO) PCI Pharma Services bused a crowd of delegates to its manufacturing site in Bedford, New Hampshire where it hosted a tour of its 50,000 square-foot expansion.

Montgomery County
Jul 24th, 2025
PCI Pharma Services Valued at $10B

PCI Pharma Services in Northeast Philadelphia has received a multibillion-dollar investment from Bain Capital and Kohlberg, valuing the company at $10 billion. Kohlberg had previously invested in PCI, while Bain is a new investor. The investment will help PCI expand its services and geographic reach. The company currently operates 38 sites across seven countries and employs over 7,500 people.

JD Supra
Jul 16th, 2025
Healthcare & Life Sciences Private Equity Deal Tracker: Bain Capital and Kohlberg Invest in PCI Pharma

Healthcare & life sciences Private Equity deal tracker: Bain Capital and Kohlberg invest in PCI Pharma.

FinSMEs
Jul 15th, 2025
PCI Pharma Services Receives Investment from Mubadala, Bain Capital, and Kohlberg

PCI Pharma, a Philadelphia, PA-based contract development and manufacturing organization (CDMO) focused on biotherapies, received an investment from Bain Capital, Kohlberg, and Mubadala Investment Company.

MarketScreener
Jul 14th, 2025
PCI Pharma Services receives new funding

PCI Pharma Services announced it received a new round of funding on July 14, 2025. The funding was co-led by new investor Bain Capital, LP, and returning investor Kohlberg & Company, L.L.C. Additional participation came from returning investors Mubadala Investment Company PJSC and Partners Group Holding AG.

INACTIVE